ELYM Old Valuation
| ELYMDelisted Stock | USD 3.09 0.06 1.90% |
At this time, the firm appears to be overvalued. ELYM Old shows a prevailing Real Value of $2.94 per share. The current price of the firm is $3.09. Our model computes the value of ELYM Old from evaluating the firm fundamentals such as Return On Asset of -0.25, current valuation of 23.84 M, and Shares Owned By Insiders of 10.38 % as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ELYM Old's price fluctuation is risky at this time. Calculation of the real value of ELYM Old is based on 3 months time horizon. Increasing ELYM Old's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ELYM stock is determined by what a typical buyer is willing to pay for full or partial control of ELYM Old. Since ELYM Old is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ELYM Stock. However, ELYM Old's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.09 | Real 2.94 | Hype 3.38 |
The intrinsic value of ELYM Old's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ELYM Old's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ELYM Old helps investors to forecast how ELYM stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ELYM Old more accurately as focusing exclusively on ELYM Old's fundamentals will not take into account other important factors: ELYM Old Total Value Analysis
ELYM Old is currently anticipated to have valuation of 23.84 M with market capitalization of 342.68 M, debt of 349 K, and cash on hands of 122.95 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ELYM Old fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
23.84 M | 342.68 M | 349 K | 122.95 M |
ELYM Old Asset Utilization
One of the ways to look at asset utilization of ELYM is to check how much profit was generated for every dollar of assets it reports. ELYM Old shows a negative utilization of assets of -0.25 percent, losing $0.002454 for each dollar of assets held by the firm. Ineffective asset utilization denotes the company is being less competent with each dollar of assets it shows. Put another way, asset utilization of ELYM Old shows how unsuccessful it operates for each dollar spent on its assets.ELYM Old Ownership Allocation
ELYM Old holds a total of 67.06 Million outstanding shares. The majority of ELYM Old outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in ELYM Old to benefit from reduced commissions. Therefore, institutional investors are subject to a different set of regulations than regular investors in ELYM Old. Please pay attention to any change in the institutional holdings of ELYM Old as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.ELYM Old Profitability Analysis
Net Loss for the year was (35.12 M) with profit before overhead, payroll, taxes, and interest of 0.About ELYM Old Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of ELYM Old. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ELYM Old based exclusively on its fundamental and basic technical indicators. By analyzing ELYM Old's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of ELYM Old's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of ELYM Old. We calculate exposure to ELYM Old's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ELYM Old's related companies.Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington. Eliem Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.
ELYM Old Growth Indicators
Investing in growth stocks can be very risky. If the company such as ELYM Old does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 27 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in ELYM Stock
If you are still planning to invest in ELYM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ELYM Old's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |